Academic Journal
The analysis of approaches to conducting bioequivalence studies and the policy of 'transparency' of their results in Ukraine, the United States and the European Union
| Title: | The analysis of approaches to conducting bioequivalence studies and the policy of 'transparency' of their results in Ukraine, the United States and the European Union |
|---|---|
| Authors: | О.S. Popov, І.V. Kravchenko, V.Ye. Dоbrоvа, K.M. Tkachenko |
| Source: | Clinical pharmacy; Vol. 25 No. 1 (2021); 32-40 Клиническая фармация; Том 25 № 1 (2021); 32-40 Клінічна фармація; Том 25 № 1 (2021); 32-40 |
| Publisher Information: | National University of Pharmacy, 2021. |
| Publication Year: | 2021 |
| Subject Terms: | дослідження біоеквівалентності, transparency policy, 9. Industry and infrastructure, политика «прозрачности», генерические ЛС, bioequivalence studies, 04 agricultural and veterinary sciences, регистрация ЛС, 16. Peace & justice, 3. Good health, реєстрація ЛЗ, 03 medical and health sciences, 0302 clinical medicine, 0404 agricultural biotechnology, генеричні ЛЗ, исследования биоэквивалентности, drug registration, generic drugs, 0405 other agricultural sciences, політика «прозорості» |
| Description: | Providing the population of Ukraine with quality, effective and, at the same time, economically affordable medicines is a priority task of the healthcare system. Taking into account the relatively low cost of their development generic drugs are available to the majority of the country’s population; thus, bioequivalence studies are needed to obtain data on their efficacy and safety. Ukraine is currently in the process of harmonizing domestic regulatory requirements for generic drugs and conducting bioequivalence studies with global ones. Therefore, it is important to find out the differences in approaches to the registration of generics and studies of their bioequivalence in Ukraine and other countries. Another important aspect is to provide the policy of “transparency” of bioequivalence research results, which contributes to the use of better drugs. Aim. To analyze domestic and global approaches to the organization of the bioequivalence research and provide the policy of “transparency” of their results. Materials and methods. A comparative analysis of approaches to drug registration, requirements for generic drugs and bioequivalence studies and ways to provide the policy of “transparency” of their results in Ukraine, the United States and the European Union was conducted. Results. The analysis has revealed that the methods of registration of drugs in Ukraine, the United States and the EU are the same. Approaches to providing the “transparency” of the results of bioequivalence studies differ since in Ukraine the publication of such information is not mandatory and is at the discretion of pharmaceutical manufacturers. Conclusions. Domestic regulatory requirements for assessing generic drugs are harmonized with the world ones. Today, there is a need to introduce a mandatory requirement for the publication of bioequivalence studies, and it will contribute to providing an effective “transparency” policy. |
| Document Type: | Article |
| File Description: | application/pdf |
| ISSN: | 2518-1572 1562-725X |
| DOI: | 10.24959/cphj.21.1548 |
| Access URL: | http://cphj.nuph.edu.ua/article/download/225755/225854 http://cphj.nuph.edu.ua/article/view/225755 |
| Rights: | CC BY |
| Accession Number: | edsair.doi.dedup.....38223daa3c8d0da94df9efb9052e9620 |
| Database: | OpenAIRE |
Be the first to leave a comment!